SHOULD WE EXPECT AN INCREASE IN CORPORATE ESPIONAGE IN THE PHARMACEUTICAL INDUSTRY OF TOMORROW?
DOI:
https://doi.org/10.5937/Rev2092037SKljučne reči:
pharmaceutical industry, patent protection, corporate espionage.Apstrakt
Corporate espionage is a process of obtaining classified information from business competitors for economic reasons and gaining an advantage over the competition. This paper is presenting an analysis of industry growth, investments in R&D and the total value of the investment estimating the possible existence of trends and activities of corporate espionage in the drug development industry. Some authors analyze the cost-effectiveness of corporate espionage compared to investing in R&D, which if shows efficient - might be determining factor in broadening prohibited activities. The results of the analysis show that growing of corporate espoionage might be expected in the future due to the growing impact of these industries on society.
Reference
Prvulovic, V. Ekonomska diplomatja/Economic Diplomacy. Megatrend Univerzitet, Belgrade, 2002.
Official Gazete of Republic of Serbia, no. 36/2011 and 99/2011.
WIPO. Available at: http://www.wipo.int/sme/en/ip_business/trade_secrets/trade_secrets.htm, Accessed on: 20/12/2018.
Jelisavac Trošić S. Todić D. Stamenović M. Svetska trgovinska organizacija – životna sredina i sistem zdravstvene zaštite. Institut za međunarodnu politku i privredu: Beograd; 2018.
Stamenovic M, Dobraca A. Benefitis of Outsourcing Strategy and IT Technology in Clinical Trials. Acta Inform Med. 2017;25(3):203–207.
Zakon o zaštiti poslovne tajne/ the Law on Protection of Business Secrets. Official Gazete of Republic of Serbia 72/2011, article 8.
Cryptogene. European Parliament. Available at: https://cr.yp.to/export/2001/09.07-europe.html, Accessed on: 05/12/ 2019.
GSA Europa. EGSA. Available at: https://www.gsa.europa.eu/european-gnss/galileo/galileo-european-global-satellite-based-navigaton-system, Accessed on: 05/12/2019.
Reuters. Available at: https://fr.reuters.com/artcle/worldNews/idUSKCN1U312I, Accessed on: 28/03/2020.
EFPIA. Available at: https://www.efpia.eu/publicatons/data-center/the-pharma-industry-in-fgures-rd/rd-intensity/, Accessed on: 28/03/2020.
Clinicaltrials.gov. Available at: www.clinicaltrials.gov. Accessed on: 28/03/2020.
DiMasi, Joseph A., et al. “Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs.” Journal of Health Economics, 2016.vol. 47.
Stamenovic M. Analiza ekonomskih podsticaja za razvoj kliničkih istraživanja unutar regiona. 7 Regionalna Konferencija o kliničkim ispitvanjima. Beograd;2017 http://www.lakodoleka.com/izvestajsa-sedme-redovne-konferencije-izazovi-u-klinickim-ispitvanjima-lekova/. Analize dostupne i putem literature pd rednim brojem (4).
WIPO. Available at: http://www.wipo.int/patents/en/, Accessed on: 05/07/2020.
Cuzovic S, Cuzovic Dj, Stamenovic M. Globalizacija –Savremeni aspekt ekonmije, trgovine i zdravstva. Ekonomski Fakultet Niš, Niš; 2019.
Marrakesh Agreement Establishing the World Trade Organization, 1867 UNTS 3, annex 1C, The Agreement on Trade Related Aspects of Intellectual Property Rights (‘TRIPS Agreement’).Available at: https://treaties.un.org/doc/Publication/UNTS/Volume%201867/volume-1867-I-31874-English.pdf, Accessed on: 05/07/2019.
Stamenović M, Gulan B, Dragaš B. Srbija danas — Savremeni aspekt neoliberalizma, ekonomije, demografije, zdravstva, bezbedost i tranzicije, Prometej: Novi Sad, 2017.
Owoeye, O.A. Data Exclusivity and Public Health under the TRIPS Agreement. Journal of Law, Information and Science. 2014-2015. Vol 23(2).
Evans GE. Strategic Patent Licensing for Public Research Organizations: Deploying Restriction and Reservation Clauses to Promote Medical R&D in Developing Countries. American Journal of Law and Medicine 2008.
Dwyer L. Patent Protection and Access to Medicine: The Colombia and Peruvian Trade Promotion Agreements. 13 Law & Business Review of the Americas, 2007.
ZIS. Available at: http://www.zis.gov.rs/upload/documents/pdf_sr/pdf/trips.pdf, Accessed on: 05/08/2020.
European Commission. Patents and Standards A modern framework for standardisation involving intellectual property rights, 2014.
ISO Available at: https://www.iso.org/standard/46032.html, Accessed on: 05/08/2020.
